ICD-10-CM Billable Code

Q75.4

Mandibulofacial dysostosis

Clinical Classification Guidelines

Inclusion Terms

  • Franceschetti syndrome
  • Treacher Collins syndrome

Medical Intelligence & Overview

Mandibulofacial dysostosis, also known as Franceschetti syndrome or Treacher Collins syndrome, is a genetic condition characterized by distinctive facial abnormalities. This condition primarily affects the development of facial bones and tissues, leading to a range of physical features that can vary in severity. Although it affects facial structure, it generally does not impact cognitive development or intelligence. The condition is inherited and present from birth, with noticeable features that can influence breathing, vision, and overall facial appearance.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting the development of facial bones and tissues Inheritance in an autosomal dominant pattern, meaning only one copy of the altered gene is sufficient to cause the disorder Certain genetic mutations involving the TCOF1 gene are most commonly associated with Treacher Collins syndrome New mutations can also occur, resulting in the disorder even if there is no family history

Key Symptoms: Underdeveloped facial bones, especially the cheekbones and jaw Downward-slanting eyes with skin folds extending to the cheeks Notched or deformed lower eyelids Absent or underdeveloped lhe upper and lower jaws, leading to breathing difficulties and feeding issues Malformed or absent ears, often leading to hearing loss Dental anomalies, including missing, misaligned, or extra teeth Narrow nasal passages with possible breathing problems Highly variable severity of facial features among individuals

Diagnostic & Treatment

Diagnosis Path: Diagnosis is typically based on physical examination and characteristic facial features observable at birth or in early childhood. Genetic testing can identify mutations in the TCOF1 gene, confirming the diagnosis. Imaging studies like X-rays or CT scans may be used to assess bony abnormalities. A comprehensive clinical assessment may involve audiological tests for hearing and evaluation of breathing and feeding difficulties. Early diagnosis allows for planning appropriate interventions and supportive care to improve quality of life.

Treatment Protocols: Management involves a multidisciplinary team approach, focusing on addressing specific health issues and improving appearance. Treatment options may include: - Surgical procedures to correct facial bone abnormalities and improve breathing, feeding, or hearing - Ear reconstruction or hearing aids for hearing impairments - Dental interventions to address alignment and missing teeth - Speech therapy to support communication skills - Ongoing evaluation and support by specialists in genetics, ENT, maxillofacial surgery, dentistry, and audiology While there is no cure for mandibulofacial dysostosis, early intervention and tailored care can significantly enhance functional and aesthetic outcomes, helping affected individuals lead more comfortable and confident lives.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q75.4 a billable ICD-10 code?
Yes, Q75.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q75.4?
Clinical documentation must specify the nature of Mandibulofacial dysostosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference